The Medtech company focuses on pre-symptomatic diagnostic tests that predict sepsis onset up to three days before symptoms appear. By providing early intervention, doctors can treat patients earlier and manage them more efficiently. Presymptom Health was founded in 2019 to exploit the intellectual property from a 10-year Ministry of Defence clinical discovery program.